2 patents
Utility
Dosage and Administration of ANTI-ERBB3 (HER3) Monoclonal Antibodies to Treat Tumors Associated with Neuregulin 1 (NRG1) Gene Fusions
15 Sep 22
Provided are methods for the clinical treatment of tumors associated with NRG1 gene fusions using anti-ERBB3 antibodies.
Shawn M. LELAND, Lori Kunkel, Doug Plessinger, Valerie Malyvanh Jansen
Filed: 10 Mar 22
Utility
Antibodies Against the Ectodomain of ERBB3 and Uses Thereof
30 Jun 22
The present invention provides a novel class of antibodies and antigen binding fragments thereof that bind the extracellular domain of ErbB3 receptor and inhibit various ErbB3 functions.
Birgit M. SCHOEBERL, Ulrik B. NIELSEN, Michael J. FELDHAUS, Arumugam MURUGANANDAM, David BUCKLER
Filed: 15 Jul 21
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first